CurveBeam AI (ASX:CVB) Common Stock: A$143.18 Mil (As of Dec. 2025)


What is CurveBeam AI Common Stock?

CurveBeam AI ASX:CVB -3.85% Common Stock is A$143.18 Mil as of Dec. 2025. The stock has 5 warning signs investors should review.

CurveBeam AI's quarterly common stock increased from Dec. 2024 (A$136.61 Mil) to Jun. 2025 (A$136.65 Mil) and increased from Jun. 2025 (A$136.65 Mil) to Dec. 2025 (A$143.18 Mil).

CurveBeam AI's annual common stock increased from Jun. 2023 (A$17.36 Mil) to Jun. 2024 (A$125.10 Mil) and increased from Jun. 2024 (A$125.10 Mil) to Jun. 2025 (A$136.65 Mil).

CurveBeam AI Common Stock Historical Data

* Premium members only.

The historical data trend for CurveBeam AI's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

CurveBeam AI Common Stock Chart

CurveBeam AI Annual Data
Trend Jun21 Jun22 Jun23 Jun24 Jun25
Common Stock
0.00 0.00 17.36 125.10 136.65

CurveBeam AI Semi-Annual Data
Jun21 Dec21 Jun22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Common Stock Get a 7-Day Free Trial Premium Member Only 125.14 125.10 136.61 136.65 143.18

CurveBeam AI Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Frequently Asked Questions Learn more about Common Stock →
What does a Common Stock of A$143.18 Mil mean?
CurveBeam AI (ASX:CVB) has a Common Stock of A$143.18 Mil as of Dec. 2025. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on CurveBeam AI and its competitors.
Is CurveBeam AI's Common Stock too high?
CurveBeam AI's current Common Stock is A$143.18 Mil.
How does CurveBeam AI's Common Stock compare to ABT and SYK?
CurveBeam AI's Common Stock of A$143.18 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Common Stock for a Medical Devices & Instruments company?
A good Common Stock depends on the Medical Devices & Instruments industry context. However, Common Stock should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Common Stock mean?
A high Common Stock can signal that a stock is expensive relative to its fundamentals. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on CurveBeam AI and its competitors. CurveBeam AI's current Common Stock is A$143.18 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CurveBeam AI stock overvalued right now?
CurveBeam AI (ASX:CVB) has a current Common Stock of A$143.18 Mil. The current Common Stock is A$143.18 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Common Stock calculated?
Common Stock is calculated from a company's financial statements. For CurveBeam AI (ASX:CVB), the current Common Stock is A$143.18 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

CurveBeam AI Business Description

Address 10 Queen Street, Level 10, Melbourne, VIC, AUS, 3000
CurveBeam AI Ltd is a manufacturer of specialized imaging equipment that has developed software that, through the use of artificial intelligence (AI), and deep learning AI (DLAI), automates the scan processing and analysis of the high-quality images produced from the company's CT devices to assist in the clinical assessment. The company has one operating segment, being the research, design, manufacture and sale of cone beam CT imaging equipment for orthopaedic specialties, which includes the development, validation and preparation for commercialisation of a HRpQCT Medical Device and Software as a Service (SaaS) platform.